The Clinical Application Study of Obinutuzumab in Pediatric Refractory Nephrotic Syndrome | MicrobiomeTrials← Back to trialsNCT07612592
The Clinical Application Study of Obinutuzumab in Pediatric Refractory Nephrotic Syndrome
RecruitingOBSERVATIONAL
Trial Details
Start: 2026-01-01Est. Completion: 2026-12-01
Enrollment target: 100 participants Locations- Chongqing medical university, Chongqing, Chongqing Municipality, China
Other microbiome trials you might be interested in
Minimal Change Disease (MCD)Membranous NephropathyGlomerulosclerosis, Focal Segmental
Minimal change disease (MCD), focal segmental glomerulosclerosis (FSGS), and Membranous nephropathy (MN), generate an en…
Los Angeles, United StatesEst. completion Dec 31, 2030
Focal Segmental Glomerulosclerosis
This study is open to adults and adolescents with a kidney condition called focal segmental glomerulosclerosis (FSGS). T…
Alabaster, United StatesEst. completion Nov 20, 2029
Nephrotic Syndrome
This randomized controlled clinical trial aims to evaluate the efficacy and safety of sodium-glucose cotransporter 2 (SG…
Al Mansurah, EgyptEst. completion Jul 5, 2026